Stopping unnecessary heart medications in older adults with Alzheimer's disease and related dementias
Deprescribing Cardiovascular Medications among Persons with and without Alzheimer's Disease and Related Dementias in Long-Term Care
This study is looking at whether stopping certain heart medications, like aspirin and statins, can be helpful for older nursing home residents with Alzheimer's and similar conditions, to see if it might reduce risks without losing important benefits.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Palo Alto Veterans Instit for Research NIH-funded |
| Lab location | 1 site (Palo Alto, United States) |
| Project ID | NIH-11122300 on NIH RePORTER |
What this research studies
This research investigates the process of deprescribing cardiovascular medications in nursing home residents, particularly those with Alzheimer's disease and related dementias. It aims to determine the effects and benefits of stopping medications like aspirin and statins in patients who may not gain significant advantages from them due to their condition. By analyzing a large cohort of approximately 150,000 residents aged 65 and older in Veteran's Health Administration nursing homes, the study seeks to provide evidence on which patients could benefit from this approach. The research will help clarify the balance between the risks of medication-related adverse events and the potential benefits of these medications.
Who could benefit from this research
Good fit: Ideal candidates for this research include nursing home residents aged 65 and older, particularly those diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are younger than 65 or those without Alzheimer's disease or related dementias may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer medication practices and improved quality of life for older adults with Alzheimer's disease and related dementias.
How similar studies have performed: While many studies have focused on starting cardiovascular medications, few have explored the effects of deprescribing, making this research a novel approach.
Where this research is happening
Palo Alto, United States
- Palo Alto Veterans Instit for Research — Palo Alto, United States (Active)
Researchers
- Principal investigator: Liu, Christine Kee — Palo Alto Veterans Instit for Research
- Study coordinator: Liu, Christine Kee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.